Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

NCT: NCT06133387 · ACTIVE_NOT_RECRUITING

NCT IDNCT06133387
StatusACTIVE_NOT_RECRUITING
Start Date2025-05-13
SponsorEndoQuest Robotics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the safety and effectiveness of the Endoluminal Surgical (ELS) System in subjects undergoing specified transanal endoluminal procedures in the rectum and sigmoid colon. Subjects will undergo endoscopic submucosal dissection (ESD), with or without closure at the discretion of the Investigator, of benign lesions in the rectum and sigmoid colon. The safety and effectiveness outcomes will be assessed intraoperatively and postoperatively at discharge and Days 7 and 30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑